Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
196 participants
OBSERVATIONAL
2014-02-28
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Actually the stages at diagnosis are about 30% in initial stages and 70% in advanced stages.
The hypothesis of this study is that a program for quick referral of patients with symptoms of head and neck cancer would help early diagnosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli
NCT02199132
Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
NCT07180901
Nasopharyngeal Carcinoma Post IMRT
NCT02597426
Predicting Toxicity in Elderly Patients With Head and Neck Cancer
NCT06344208
Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial
NCT05338905
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
New diagnosed patients of head and neck cancer
New diagnosed patients of head and neck cancer
Quick diagnosis program
Old diagnosed head and neck cancer patients
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quick diagnosis program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Corporacion Parc Tauli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rosa Rosell Ferrer
PhD MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Corporacio Sanitaria Parc Tauli
Sabadell, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSPT_ORL_2014_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.